|
font size:
|
 |
 |
|
 |
|
| |
|
| Date |
Event |
Location |
ProNAi Presentation |
| April 6-10, 2013 |
AACR |
Washington, D.C. |
Abstract #3529 presented by Wendi Rodrigueza, CSO, and Richard Messmann, CMO |
| Nov. 6-9, 2012 |
EORTC-NCI-AACR |
Dublin, Ireland |
Abstract #620 presented by Richard Messmann, CMO |
| June 1-5, 2012 |
ASCO |
Chicago, IL |
Abstract #TPS3110 presented by Wendi Rodrigueza, CSO, and Drew Rasco, START |
| May 22-24, 2012 |
C21 |
Napa, CA |
Presentation by Mina Sooch, CEO |
| April 1-4, 2012 |
AACR |
Chicago, IL |
Abstract #2764 presented by Wendi Rodrigueza, CSO |
| October 25-26, 2011 |
BIO Investor Forum |
San Francisco, CA |
Charles Bisgaier, CEO |
| May 24-26, 2011 |
C21 BioVentures |
Napa, CA |
Charles Bisgaier, CEO |
| Nov. 10-11, 2010 |
8th Annual MidAmerica Healthcare Venture Forum |
Detroit, MI |
Charles Bisgaier, ProNAi CEO |
| August 23-24, 2007 |
Sixth International Congress on Targeted Therapies in Oncology |
Washington, DC |
Donald Anderson, ProNAi CMO |
| June 20-21, 2007 |
Beyond Genome |
San Francisco, CA |
June 21 – 2 pm (Richard Gill, Chairman) and 4:30 pm session (Richard Gill, Moderator) |
| June 19-20, 2007 |
Dow Jones Health Care Innovations |
Redwood City, CA |
June 19 - 11:40 am
Richard Gill, President and CEO, to present |
|
|
|
